Life sciences business OptiBiotix Health plc (AIM: OPTI) has launched its SlimBiome-based GoFigure products on Amazon India, targeting the world's most populous nation and its growing consumer base.

India, with obesity rates at 40.3% and projected to have the largest medium-to-high income population by 2035, offers significant opportunities for weight management products.

GoFigure products will also remain available through Apollo Pharmacies, both in-store and online, as part of a multi-channel strategy to drive growth in high-potential markets. The Amazon launch coincides with a rebranding effort featuring more vibrant packaging and prominent Fossence branding, leveraging consumer trust in Tata's proprietary ingredient.

OptiBiotix, founded in 2012, develops microbiome-modifying compounds addressing obesity, cardiovascular health and diabetes. Its partnerships with over 20 global food and healthcare companies further enhance its position in the wellness market.